Barclays Keeps Their Sell Rating on Patterson Companies Inc (PDCO)


In a report released yesterday, Steven Valiquette from Barclays maintained a Sell rating on Patterson Companies Inc (PDCO), with a price target of $20. The company’s shares closed yesterday at $22.55.

According to TipRanks.com, Valiquette is a 3-star analyst with an average return of 2.5% and a 48.5% success rate. Valiquette covers the Services sector, focusing on stocks such as AmerisourceBergen Corporation, WellCare Health Plans, and Molina Healthcare.

Currently, the analyst consensus on Patterson Companies Inc is a Moderate Sell with an average price target of $22.33.

See today’s analyst top recommended stocks >>

Patterson Companies Inc’s market cap is currently $2.14B and has a P/E ratio of 13.54. The company has a Price to Book ratio of 1.47.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Patterson Cos., Inc. engages in the research, development, and sale of dental, veterinary, and rehabilitation supplies. It operates through the following segments: Dental, Animal Health, and Corporate.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts